Abstract
Mammographic density is strongly associated with breast cancer risk. Inflammation is involved in breast carcinogenesis, perhaps through effects on mammographic density. We evaluated associations between inflammatory markers interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP) and mammographic density among postmenopausal women. Plasma IL-6, TNF-α, and CRP levels were measured in 145 women with benign breast disease (benign controls) and 397 women with a negative screening mammogram (well controls) enrolled in the Mammograms and Masses Study. Associations between the inflammatory markers and mammographic density were evaluated separately for benign and well controls through correlation analyses and linear regressions. Age-adjusted mean CRP levels were higher among benign controls (2.07 μg/ml) compared to well controls (1.63 μg/ml; P = 0.02), while IL-6 and TNF-α levels were similar between groups. Using linear regression, IL-6, TNF-α, and CRP were not statistically significantly associated with dense breast area within either group. Statistically significant positive associations were observed between all three markers and nondense breast area in both groups; statistically significant negative associations were observed between IL-6 and percent density among benign controls, and between all three markers and percent density among well controls. These associations were all attenuated and non-significant upon adjustment for body mass index. IL-6, TNF-α, and CRP levels were not independently associated with dense breast area, nondense breast area, or percent density in this study population. Our results suggest that these inflammatory factors do not impact breast carcinogenesis through independent effects on mammographic density.
Similar content being viewed by others
Abbreviations
- ANOVA:
-
Analysis of variance
- BMI:
-
Body mass index
- COX-2:
-
Cyclooxygenase-2
- CRP:
-
C-reactive protein
- ELISA:
-
Enzyme-linked immunosorbent assay
- IL-6:
-
Interleukin-6
- LCBR:
-
Laboratory for Biochemsitry Research
- MAMS:
-
Mammograms and Masses Study
- NSAID:
-
Non-steroidal anti-inflammatory drug
- TNF-α:
-
Tumor necrosis factor alpha
References
Boyd NF, Martin LJ, Rommens JM et al (2009) Mammographic density: a heritable risk factor for breast cancer. Methods Mol Biol 472:343–360
Wolfe JN (1976) Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol 126:1130–1137
Wolfe JN (1969) The prominent duct pattern as an indicator of cancer risk. Oncology 23:149–158
Torres-Mejia G, De Stavola B, Allen DS et al (2005) Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies. Cancer Epidemiol Biomarkers Prev 14:1052–1059
Kato I, Beinart C, Bleich A et al (1995) A nested case-control study of mammographic patterns, breast volume, and breast cancer. Cancer Causes Control 6:431–438
Byrne C, Schairer C, Wolfe J et al (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87:1622–1629
Boyd NF, Dite GS, Stone J et al (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347:886–894
Greendale GA, Reboussin BA, Slone S et al (2003) Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95:30–37
Morimoto LM, White E, Chen Z et al (2002) Obesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative. Cancer Causes Control 13:741–751
Harvey JA, Pinkerton JV, Herman CR (1997) Short-term cessation of hormone replacement therapy and improvement of mammographic specificity. J Natl Cancer Inst 89:1623–1625
Ursin G, Parisky YR, Pike MC et al (2001) Mammographic density changes during the menstrual cycle. Cancer Epidemiol Biomarkers Prev 10:141–142
Key T, Appleby P, Barnes I et al (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616
Kaaks R, Rinaldi S, Key TJ et al (2005) Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12:1071–1082
Reeves GK, Beral V, Green J et al (2006) Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol 7:910–918
Shah NR, Borenstein J, Dubois RW (2005) Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis. Menopause 12:668–678
Cotterchio M, Kreiger N, Sloan M et al (2001) Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10:1213–1217
Harris RE, Chlebowski RT, Jackson RD et al (2003) Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women’s Health Initiative. Cancer Res 63:6096–6101
Khuder SA, Mutgi AB (2001) Breast cancer and NSAID use: a meta-analysis. Br J Cancer 84:1188–1192
Terry MB, Gammon MD, Zhang FF et al (2004) Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 291:2433–2440
Gallicchio L, McSorley MA, Newschaffer CJ et al (2006) Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease. Cancer 106:1443–1452
DuBois RN (2004) Aspirin and breast cancer prevention: the estrogen connection. JAMA 291:2488–2489
Reed MJ, Purohit A (1997) Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocr Rev 18:701–715
Purohit A, Reed MJ (2002) Regulation of estrogen synthesis in postmenopausal women. Steroids 67:979–983
Carr BR, Bradshaw KD (2001) Disorders of the ovary and female reproductive tract. In: Braunwald E, Fauci AS, Kasper DL et al (eds) Harrison’s principles of internal medicine, 15th edn. McGraw-Hill, New York, NY
Bogaty P, Brophy JM, Noel M et al (2004) Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study. Circulation 110:934–939
Il’yasova D, Colbert LH, Harris TB et al (2005) Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 14:2413–2418
Heikkila K, Harris R, Lowe G et al (2009) Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 20:15–26
Bhandare D, Nayar R, Bryk M et al (2005) Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer. Cancer Epidemiol Biomarkers Prev 14:2620–2627
Gonullu G, Ersoy C, Ersoy A et al (2005) Relation between insulin resistance and serum concentrations of IL-6 and TNF-alpha in overweight or obese women with early stage breast cancer. Cytokine 31:264–269
Caras I, Grigorescu A, Stavaru C et al (2004) Evidence for immune defects in breast and lung cancer patients. Cancer Immunol Immunother 53:1146–1152
DeKeyser FG, Wainstock JM, Rose L et al (1998) Distress, symptom distress, and immune function in women with suspected breast cancer. Oncol Nurs Forum 25:1415–1422
Krajcik RA, Massardo S, Orentreich N (2003) No association between serum levels of tumor necrosis factor-alpha (TNF-alpha) or the soluble receptors sTNFR1 and sTNFR2 and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12:945–946
Campbell MJ, Scott J, Maecker HT et al (2005) Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Res Treat 91:163–171
Sheen-Chen SM, Chen WJ, Eng HL et al (1997) Serum concentration of tumor necrosis factor in patients with breast cancer. Breast Cancer Res Treat 43:211–215
Allin KH, Bojesen SE, Nordestgaard BG (2009) Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 27:2217–2224
Zhang SM, Lin J, Cook NR et al (2007) C-reactive protein and risk of breast cancer. J Natl Cancer Inst 99:890–894
Trichopoulos D, Psaltopoulou T, Orfanos P et al (2006) Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev 15:381–384
Siemes C, Visser LE, Coebergh JW et al (2006) C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 24:5216–5222
Lithgow D, Nyamathi A, Elashoff D et al (2007) C-reactive protein in nipple aspirate fluid associated with Gail model factors. Biol Res Nurs 9:108–116
Reeves KW, Gierach GL, Modugno F (2007) Recreational physical activity and mammographic breast density characteristics. Cancer Epidemiol Biomarkers Prev 16:934–942
Hudson AG, Gierach GL, Modugno F et al (2008) Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17:680–687
Palomares MR, Machia JR, Lehman CD et al (2006) Mammographic density correlation with Gail model breast cancer risk estimates and component risk factors. Cancer Epidemiol Biomarkers Prev 15:1324–1330
Haars G, van Noord PA, van Gils CH et al (2005) Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomarkers Prev 14:2634–2640
Boyd NF, Martin LJ, Sun L et al (2006) Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15:2086–2092
Reeves KW, Stone RA, Modugno F et al (2009) Longitudinal association of anthropometry with mammographic breast density in the Study of Women’s Health Across the Nation. Int J Cancer 124:1169–1177
Woolcott CG, Cook LS, Courneya KS et al (2010) Associations of overall and abdominal adiposity with area and volumetric mammographic measures among postmenopausal women. Int J Cancer. doi:10.1002/ijc.25676
Himmerich H, Fulda S, Linseisen J et al (2006) TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. Eur Cytokine Netw 17:196–201
Bochud M, Marquant F, Marques-Vidal PM et al (2009) Association between C-reactive protein and adiposity in women. J Clin Endocrinol Metab 94:3969–3977
Weisberg SP, McCann D, Desai M et al (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–1808
Sunderkotter C, Steinbrink K, Goebeler M et al (1994) Macrophages and angiogenesis. J Leukoc Biol 55:410–422
Garcia-Macedo R, Sanchez-Munoz F, Almanza-Perez JC et al (2008) Glycine increases mRNA adiponectin and diminishes pro-inflammatory adipokines expression in 3T3–L1 cells. Eur J Pharmacol 587:317–321
Kolsum U, Roy K, Starkey C et al (2009) The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year. Int J Chron Obstruct Pulmon Dis 4:149–156
Karakas M, Baumert J, Greven S et al (2010) Reproducibility in serial C-reactive protein and interleukin-6 measurements in post-myocardial infarction patients: results from the AIRGENE study. Clin Chem 56:861–864
Acknowledgments
This work was supported by Department of Defense Grant BC050518 and National Institutes of Health Grant R25 CA057703. Additional support was provided by funds received from the National Institutes of Health/National Center for Research Resources/General Clinical Research Center Grant MO1-RR000056.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reeves, K.W., Weissfeld, J.L., Modugno, F. et al. Circulating levels of inflammatory markers and mammographic density among postmenopausal women. Breast Cancer Res Treat 127, 555–563 (2011). https://doi.org/10.1007/s10549-010-1249-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-010-1249-5